Results 291 to 300 of about 20,833,504 (341)

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Keys to female athlete performance in Paris 2024. [PDF]

open access: yesFront Psychol
Boz E   +7 more
europepmc   +1 more source

The influence of surface-wall roughness on hydrocyclone performance

open access: hybrid
Arjun Kumar Pukkella   +3 more
openalex   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

GPT-4o and OpenAI o1 Performance on the 2024 Spanish Competitive Medical Specialty Access Examination: Cross-Sectional Quantitative Evaluation Study.

open access: yesJMIR Med Educ
Benito P   +9 more
europepmc   +1 more source

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study. [PDF]

open access: yesClinicoecon Outcomes Res
Alruthia Y   +7 more
europepmc   +1 more source

Climbing the gap: a review on sex differences in high-level rock climbing. [PDF]

open access: yesFront Sports Act Living
Langer K   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy